Lung Cancer Testing : The Past CXR / sputum screening

@inproceedings{Tanner2017LungCT,
  title={Lung Cancer Testing : The Past CXR / sputum screening},
  author={Nichole T Tanner and Hiren Mehta and Gerard A. Silvestri},
  year={2017}
}
At the time of presentation, only 16% of p,atients are diagnosed with a disease stage that has potential for cure by surgical resection. The overall 5-year survivorship for all patients is 15%, despite therapy. However, the 5-year survival for those with pathologic stage I non–small-cell lung cancer (NSCLC) is 58% to 73% after surgery.[2] This significant… CONTINUE READING